Emerging Infectious Disease ISSN: 1080-6059

Community Prescribing and Resistant Streptococcus pneumoniae

Galia Barkai*, David Greenberg*, Noga Givon-Lavi*, Eli Dreifuss†, Daniel Vardy†, and Ron Dagan*

Author affiliations: *Soroka University Medical Center and Ben-Gurion University of the Negev, Beer-Sheva, Israel; †Israel General Health Insurance Plan, Beer-Sheva, Israel

Main Article

Figure 3

Proportions of erythromycin-resistant and multidrug-resistant Streptococcus pneumoniae isolated during episodes of acute otitis media in Bedouin and Jewish children <5 years of age in southern Israel from 1999 through 2003. Ery-R, erythromycin resistance; MDR, multidrug resistance (resistance to ≥3 antimicrobial classes).

Figure 3. . Proportions of erythromycin-resistant and multidrug-resistant Streptococcus pneumoniae isolated during episodes of acute otitis media in Bedouin and Jewish children <5 years of age in southern Israel from 1999 through 2003. Ery-R, erythromycin resistance; MDR, multidrug resistance (resistance to ≥3 antimicrobial classes).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.